A seven-stock IPO countdown spans cybersecurity, vertical software, networking, travel technology and biospecimen markets, including FatPipe, Navan and Netskope.
The IPO market has entered 2026 with a reopening narrative, but this is not a return to indiscriminate issuance. Improved risk appetite, stronger retail participation and a backlog of mature private companies are bringing more businesses to public markets, while investors remain selective about scale, profitability and aftermarket performance. That makes newly listed companies a useful lens on where public-market capital is flowing. The opportunity is broad, but the risks are equally visible: valuations can move quickly, operating histories are often short and headline enthusiasm can outpace financial performance.
The most important IPO segments now include blockbuster listings, private-equity-backed exits and the broader group of $1 billion to $30 billion offerings that best reflects market health. AI and AI infrastructure remain major sub-themes, joined by cybersecurity, software, healthcare, consumer platforms, financial technology and energy infrastructure. Anthropic’s November 19, 2026 IPO has become a marquee event for the market, illustrating how AI enthusiasm is intersecting with public-market demand, valuation scrutiny and heavy capital requirements. The result is a market where business quality matters more than deal count alone.
This countdown examines seven US-listed IPO-related companies across financial services, software, cybersecurity, networking, travel technology and healthcare research. The ranking runs from #7 to #1, moving from the weakest combination of thematic depth and fundamentals to the strongest. Some names offer direct exposure to the latest issuance trends, while others are established public companies that still represent important post-IPO case studies. Each section weighs what the company sells, how closely it fits the IPO theme, the financial evidence available today and the latest earnings signals.
Our screen focuses on US-listed companies with market capitalizations above $500 million and then prioritizes depth of exposure to the IPO theme before considering business fundamentals. The review uses primary-source company descriptions, market data, valuation measures, profitability, growth metrics, analyst consensus and recent earnings history. The result is a countdown rather than a broad market survey: the list begins with #7 and works toward the best overall pick at #1. Grades are presented as composite quality measures, while analyst figures are reported separately so readers can distinguish operating evidence from market expectations.
What they do. The company operates iSpecimen Marketplace, a proprietary online marketplace connecting medical researchers seeking subjects, biospecimens and data with hospitals, laboratories and other organizations that provide them. Its catalog includes blood products, tissue, fluids and immune or hematopoietic cells, serving biopharmaceutical, in vitro diagnostics, government and academic customers.
Why it fits. iSpecimen offers direct healthcare and biotechnology exposure through a marketplace model that connects research demand with sample supply. Its June 17, 2021 IPO also makes it an established member of the post-IPO cohort, although its small current capitalization and weak financial profile place it last in this countdown.
Numbers that matter. Revenue is $603,744, with year-over-year revenue growth of 128.9%, but EBITDA is negative $8,714,781. The gross margin is negative 42.1% and the operating margin is negative 14.5533%, while ROE is negative 3.0391 and ROA is negative 0.5874. TTM EPS is negative $52.98, and no trailing or forward P/E is available in the supplied valuation data.
Recent momentum. The latest reported EPS loss was $1.03 on November 17, 2026, following a $0.98 loss on August 14. The supplied earnings history shows a 0/2 beat rate; the May 29 loss of $6.6648 missed the $0.31 estimate by 129.0%, and the reported analyst target is $3 without a published consensus breakdown.
What they do. FatPipe develops application-aware software-defined wide area networking, secure access service edge and network monitoring solutions. It sells through a subscription-based model using distributors, value-added resellers, internet service providers and other third parties, serving enterprises, communications and security providers, government organizations and middle-market companies.
Why it fits. The company is a direct post-IPO software-infrastructure play, having listed on April 8, 2025. Its SD-WAN, SASE and network-monitoring products align with the IPO market’s technology and infrastructure sub-themes, while the subscription distribution model gives investors a clearer recurring-revenue framework than many early-stage listings.
Numbers that matter. Revenue is $21,178,740, up 22.1% year over year, while earnings growth is 74.0%. Profitability is a major strength: gross margin is 90.3%, operating margin is 20.46%, net margin is 31.64%, ROE is 27.51% and ROA is 8.01%. TTM EPS is $0.47, EBITDA is $4,592,330, and trailing and forward P/E ratios are 9.0638 and 9.3458, respectively.
Recent momentum. FatPipe has beaten estimates in each of the three comparable quarters in the supplied history. On November 4, EPS of $0.09 exceeded the $0.04 estimate by 125.0%; the July 30 result of $0.09 beat $0.07 by 28.6%, and the May 18 result of $0.3421 beat $0.10 by 242.1%. The reported analyst consensus is 5.0, with an average target of $10.
What they do. Navan operates an AI-powered platform for business travel, payments and expense management. The system covers booking, policy enforcement, payment processing, expense reconciliation and reporting, and the company also identifies an OpenTable partnership for AI-powered business travel planning.
Why it fits. Navan is a clear example of the newer AI-enabled software cohort, with its October 30, 2025 IPO placing it close to the current reopening wave. Its exposure is tied to enterprise travel and expense workflows rather than AI infrastructure, but the platform’s use of AI across booking and reporting gives it a direct connection to one of the market’s strongest IPO sub-themes.
Numbers that matter. Revenue is $825,873,024, up 35.4% year over year, but EBITDA is negative $161,020,000 and net margin is negative 42.11%. Gross margin is 72.6%, while operating margin is negative 24.74%, ROE is negative 49.39% and ROA is negative 8.67%. TTM EPS is negative $1.40, the next-year EPS estimate is negative $0.4129 and forward P/E is 73.5294, leaving the stock dependent on continued growth and eventual margin improvement.
Recent momentum. The earnings beat rate is 3/4. The September 9 loss of $0.12 matched the estimate, while the June 10 loss of $0.06 was better than the $0.12 estimate by 50.0%; the March 25 result of $0.02 also exceeded the negative $0.11 estimate. Four Buy ratings are reported, and the analyst consensus is 4.7333 with an average target of $30.9333.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
What they do. Netskope provides the Netskope One cloud-native platform for enterprise security, networking and analytics. Its product set includes cloud access security, data loss prevention, threat protection, secure web gateway, private access, software-defined wide area networking, firewall-as-a-service and analytics covering user activity, data movement and security events.
Why it fits. Netskope’s September 18, 2025 IPO provides direct exposure to the cybersecurity and cloud-infrastructure segments that have become central to the modern IPO market. The breadth of Netskope One, spanning security, connectivity and analytics, gives the company unusually deep thematic exposure for a recently listed enterprise software name.
Numbers that matter. Revenue is $802,636,032, with year-over-year growth of 29.2%, and gross margin is 69.9%. Profitability remains the central weakness: operating margin is negative 94.23%, net margin is negative 91.84%, ROA is negative 37.23% and EBITDA is negative $720,739,968. TTM EPS is negative $1.52, the next-year EPS estimate is negative $1.0918 and forward P/E is 526.3158.
Recent momentum. Netskope has beaten estimates in all four comparable quarters. On September 2, EPS of negative $0.19 was better than the negative $0.26 estimate by 26.9%, and the June 3 result of negative $0.06 beat the negative $0.07 estimate by 14.3%. The analyst breakdown reports four Buy ratings and three Hold ratings, with consensus at 4.4737 and an average target of $22.1316.
What they do. ServiceTitan provides an end-to-end cloud platform that connects advertising, scheduling, dispatching, estimates, invoicing and payments for contractors. It also offers FieldRoutes for pest control, Aspire for landscaping and related industries, plus payment processing and third-party financing products through its FinTech offering.
Why it fits. ServiceTitan’s December 12, 2024 IPO is a strong example of a later-stage vertical software listing. Its focus on specialized contractor workflows gives investors exposure to application software and embedded financial services, while the platform’s presence across HVAC, plumbing, electrical, landscaping and pest control creates a broad end-market base.
Numbers that matter. Revenue is $1,064,729,984, up 20.9% year over year, with gross margin of 71.2%. The company remains unprofitable on the supplied measures: operating margin is negative 12.6%, net margin is negative 12.12%, ROE is negative 8.34%, ROA is negative 4.67% and EBITDA is negative $74,085,000. TTM EPS is negative $1.36, but the next-year EPS estimate is $1.0988; forward P/E is 47.1698.
Recent momentum. The supplied earnings history shows a 6/7 beat rate. The September 8 loss of $0.25 missed the negative $0.09 estimate by 177.8%, but the June 4 result of $0.37 beat $0.28 by 32.1%, and the March 12 result of $0.27 beat $0.18 by 50.0%. Analysts report three Buy ratings and three Hold ratings, with consensus at 4.5 and an average target of $96.8125.
Pick #2Premium members only
Premium members see this pick's full breakdown — investment thesis, key financial metrics, recent earnings execution, and analyst consensus.
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
This monthly screen covers US-listed IPO-related companies and applies a market-cap threshold of more than $500 million before evaluating the supplied candidates. Ranking is based first on depth of exposure to the IPO theme, including direct post-IPO status and participation in key segments such as AI, cybersecurity, fintech, blockchain and software infrastructure. Business fundamentals then determine the order within that thematic universe, with emphasis on revenue growth, margins, earnings history, valuation and analyst expectations. The article is refreshed monthly because IPO aftermarket performance, earnings results and consensus targets can change rapidly. The presentation remains a countdown from #7 to the best pick at #1.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.